H.C. Wainwright analyst Douglas Tsao has reiterated their bullish stance on VRDN stock, giving a Buy rating today.Pick the best stocks and maxi ...

Viridian was one of my top picks in 2022 and it made the 2023 list again. Click here to see our take on VRDN stock. Skip to content. ... Investing Group Leader Premium. Comments (2.91K) ...

EVE Online has just received its latest expansion with Viridian, complete with a brand new trailer from CCP Games today. Published Tue, 13 Jun 2023 07:12:11 -0500 by Gavin Sheehan ...

Viridian is also advancing VRDN-003 as a potential best-in-class subcutaneous therapy for the treatment of TED, including two ongoing global phase 3 pivotal clinical trials, REVEAL-1 and REVEAL-2 ...

Viridian Therapeutics' experimental treatment for chronic thyroid eye disease (TED) significantly reduced symptoms such as double vision and eye bulging in a late-stage study, sending its shares ...

Viridian Therapeutics said on Tuesday its experimental treatment helped significantly reduce symptoms of thyroid eye disease (TED) in a late-stage study, setting the stage to become the first ...

Shares of Viridian Therapeutics Inc. VRDN fell in the extended session Monday after the biotech drug maker said it was making changes to its study design for a chronic thyroid eye disease therapy ...

Viridian Weapon Technologies has announced the availability of two new weapon-mounted accessories for the Sig Sauer P365: The REACTOR R5 Gen 2 Green Laser Sight and the E-SERIES Red Laser Sight.